Results 51 to 60 of about 79,961 (249)

Mental health effects of past and current pandemics on health-care professionals: A narrative review

open access: yesIndian Journal of Social Psychiatry, 2023
During the coronavirus disease-19 (COVID-19) crisis, health-care workers (HCWs) across the world are facing a high risk of infection and increased workload. This makes them vulnerable to the psychological effects of the pandemic.
Kamaldeep Sadh   +2 more
doaj   +1 more source

KENALI EBOLA

open access: yesJurnal kedokteran dan kesehatan Indonesia, 2014
No ...
openaire   +4 more sources

Rational Design of Broad‐Spectrum Anti‐Enteroviral Molecular Glues Targeting Enteroviral RNAi Suppressors

open access: yesAdvanced Science, EarlyView.
By leveraging this homodimerization mechanism, molecular glues were rationally designed to induce dysfunctional 3A dimerization, thereby restoring antiviral RNAi. The optimal molecular glue, VTP‐32, demonstrated potent and pan‐enterovirus (groups A, B, D) antiviral effects.
Yuan Fang   +13 more
wiley   +1 more source

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Ebola hemorrhagic fever, also known as Ebola virus disease or EVD, is one of the most dangerous viral diseases in humans and animals. In this open-label, dose-escalation clinical trial, we assessed the safety, side effects, and immunogenicity of a novel,
I. V. Dolzhikova   +35 more
doaj   +1 more source

Dynamics of host-reservoir transmission of Ebola with spillover potential to humans

open access: yesElectronic Journal of Qualitative Theory of Differential Equations, 2018
Ebola virus disease (EVD) is a zoonotic borne disease (i.e. disease that is spread from animals to people). Therefore human beings can be infected through direct contact with an infected animal (fruit-eating bat or great ape).
Berge Tsanou   +3 more
doaj   +1 more source

Living Microbial Drugs

open access: yesChemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

The Ebola outbreak in comparison: Liberia and Côte d’Ivoire [PDF]

open access: yes, 2015
West Africa has been fighting its first epidemic of the Ebola virus disease for more thana year now. Despite a decline of infections, especially in urban centres, new cases stillemerge and call for continued vigilance.
Kaufmann, Andrea   +2 more
core  

Membrane‐Permeable Nucleoside T‐1106 Diphosphate and Triphosphate Analogues as Antiviral Pronucleotides

open access: yesChemistry – A European Journal, EarlyView.
Favipiravir (T‐705) and the non‐fluorinated counterpart (T‐1106) are antiviral agents that inhibit the RNA‐dependent RNA polymerase (RdRp) of various RNA viruses. The antiviral efficacy of nucleoside analogues is strongly dependent on their intracellular activation by cellular kinases to produce their corresponding triphosphate metabolites (T‐705‐RTP ...
Chris Meier   +7 more
wiley   +1 more source

Efficacy of control measures in the control of Ebola, Liberia 2014–2015

open access: yesJournal of Biological Dynamics, 2018
The largest outbreak of Ebola to date is the 2014 West Africa Ebola outbreak, with more than 10,000 cases and over 4000 deaths reported in Liberia alone.
Necibe Tuncer   +3 more
doaj   +1 more source

Resurgence of Sudan Virus Disease (SUVD) in Uganda

open access: yesGlobal Biosecurity, 2022
On September 20th, 2022, a case of ebola virus disease was confirmed in Uganda by the World Health Organization. The presumed index case of a 24-year-old male was sequenced and identified as the Sudan strain. This was the first known outbreak of ebola in
Damian Alexander Honeyman   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy